Bellis Pharmaceuticals Limited
About Bellis Pharmaceuticals Limited
Data last updated:
Bellis Pharmaceuticals Limited was a public limited company based in Bangalore, Karnataka, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the manufacturing segment of the chemicals sector. It was incorporated on 14 October 2009.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2009PLC051193. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Prakashchand Jain and Dhanraj Ostawal.
Its last annual general meeting (AGM) was held on 31 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at # 175/7 Bharat Complex A.S.Char Street, Bangalore, Karnataka, India – 560053.
Company details
Contact details
Bellis Pharmaceuticals Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address# 175/7 Bharat Complex A.S.Char Street, Bangalore, Karnataka, India – 560053
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Bellis Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bellis Pharmaceuticals Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bellis Pharmaceuticals Limited, buy the company report.
Board of directors of Bellis Pharmaceuticals Limited
Bellis Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakashchand Jain | Director | 21 Aug 2016 | 10 Years 2 Months | As last reported |
| Dhanraj Ostawal | Director | 14 Oct 2009 | 17 Years 0 Months | As last reported |
| Sunil Dhanraj Ostwal | Director | 14 Oct 2009 | 17 Years 0 Months | As last reported |
Auditor
Bellis Pharmaceuticals Limited is audited by R.H SETHIA ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.H SETHIA ASSOCIATES | FY 2017 | 207680 |
Shareholding
The shareholding of Bellis Pharmaceuticals Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Bellis Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bellis Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bellis Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bellis Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bellis Pharmaceuticals Limited, buy the company report.
Recent activity
Bellis Pharmaceuticals Limited has 5 board changes on record since 2009: 3 appointments and 2 cessations. The latest: Prakashchand Jain ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
Bellis Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Bellis Pharmaceuticals was a public limited company based in Bangalore, Karnataka, India. The company worked in manufacturing, within the chemicals industry. It was incorporated on 14 October 2009 and is registered under CIN U24232KA2009PLC051193. The company has been struck off by the Registrar of Companies and is no longer operational.
Bellis Pharmaceuticals had 3 directors:
- Prakashchand Jain - Director
- Dhanraj Ostawal - Director
- Sunil Dhanraj Ostwal - Director
The CIN (Corporate Identification Number) of Bellis Pharmaceuticals is U24232KA2009PLC051193. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Bellis Pharmaceuticals is at # 1757 Bharat Complex A.S.Char Street, Bangalore, Karnataka, India – 560053.
Bellis Pharmaceuticals was incorporated on 14 October 2009. It is registered with the Registrar of Companies, Bangalore.
The latest financial statements of Bellis Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 July 2023. Year-wise statements from 2015 are in the company report.
No. Bellis Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Bellis Pharmaceuticals operated in the chemicals industry, in the manufacturing segment. It worked in this industry before it was struck off.
Prakashchand Jain ceased to be Additional Director on 30 Sep 2017. Matrika Prasad Joshi ceased to be Director on 21 Aug 2016. Prakashchand Jain was appointed as Director on 21 Aug 2016. Bellis Pharmaceuticals has 5 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
